RxDoctor Payments Data

Franklin Lowe, MD

Family Medicine · Los Alamitos, CANPI 1629097613

Payments from drug & device makers

$15,443in general payments, 2019–2025

Across 773 payments — averaging $19.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$3K
  • AbbVie$1K
  • Novartis$888
  • GSK$818
  • Takeda Pharmaceuticals U.S.A., Inc.$755
  • Lilly USA, LLC$669
  • plus $8K from 54 others

What the payments were for

  • Speaking & faculty fees$370%
  • Food & beverage$15,32299%
  • Education$270%
  • Gifts$580%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)181$3,088
AbbVie(2 entities)71$1,335
Novartis43$888
GSK38$818
Takeda Pharmaceuticals U.S.A., Inc.32$755
Lilly USA, LLC32$669
Amarin Pharma, Inc.49$640
Bausch Health US, LLC31$606
AstraZeneca25$578
Radius Health, Inc.23$552
Grifols USA, LLC17$407
Regeneron Healthcare Solutions, Inc.20$406
Arbor Pharmaceuticals, Inc.17$330
Cleerly, Inc.4$322
Azurity Pharmaceuticals, Inc.12$289
Paratek Pharmaceuticals, Inc.11$232
Pfizer11$207
Merck11$189
Novo Nordisk11$186
Lundbeck LLC7$180
Bayer6$165
Inspire Medical Systems, Inc.3$159
Esperion Therapeutics, Inc.8$150
Antares Pharma, Inc.9$147
Edwards Lifesciences5$125
Kowa Pharmaceuticals America, Inc.7$117
Biohaven Pharmaceuticals, Inc.6$110
Ascend Therapeutics US, LLC5$106
Almatica Pharma LLC4$103
Boehringer Ingelheim4$100
Currax Pharmaceuticals LLC7$100
Astellas Pharma US Inc3$94
Phathom Pharmaceuticals, Inc.4$93
Hikma Pharmaceuticals USA6$90
Medicure Pharma Inc.3$85
Octapharma USA, Inc.1$81
Scilex Pharmaceuticals Inc.5$80
Acerus Pharmaceuticals Corporation3$54
Therapeuticsmd, Inc.3$53
Alvogen Inc2$47
Genentech USA, Inc.2$45
Johnson & Johnson2$41
Cumberland Pharmaceuticals, Inc.1$40
Verity Pharmaceuticals Inc.1$40
Embecta Corp.1$36
Biohaven Pharmaceutical Holding Company Ltd.2$36
Axsome Therapeutics, Inc.1$29
Concordia Pharmaceuticals Inc.1$24
Dermira, Inc.1$24
Vertical Pharmaceuticals, LLC1$24
Irhythm Technologies, Inc.1$24
Baxter Healthcare1$23
Biogen1$23
Impel Pharmaceuticals Inc.1$22
Clarus Therapeutics Inc.1$21
Eisai Inc.1$21
Phadia US Inc.1$21
Exact Sciences1$21
Sanofi-aventis U.S. LLC1$20
Ultragenyx Pharmaceutical Inc.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,443 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$151,698
Medicare patients
157
Services billed
3,070

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Repatha SureclickEvolocumab195$191,326
TymlosAbaloparatide13$58,358
ProliaDenosumab31$53,254
VascepaIcosapent Ethyl84$52,221
Gamunex-CImmune Globul G/Gly/Iga Avg 4624$42,546
Trelegy ElliptaFluticasone/Umeclidin/Vilanter60$38,482
JanuviaSitagliptin Phosphate40$35,547
MounjaroTirzepatide28$33,642
TrintellixVortioxetine Hydrobromide36$26,408
Xigduo XrDapaglifloz Propaned/Metformin19$25,261
Praluent PenAlirocumab15$21,028
EliquisApixaban17$20,008
Icosapent Ethyl58$19,579
EdarbiAzilsartan Medoxomil41$19,329
JardianceEmpagliflozin16$19,073

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Radius Health, Inc.Tymlos$552$58,35813 claims
AmgenProlia$3,088$53,25431 claims
Lilly USA, LLCMounjaro, Trulicity$669$49,71443 claims
Grifols USA, LLCGamunex-C$407$42,54624 claims
GSKTrelegy Ellipta$818$38,48260 claims
MerckJanuvia$189$35,54740 claims
PfizerEliquis, Premarin$207$26,67140 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$755$26,40836 claims
Arbor Pharmaceuticals, Inc.Edarbi, Edarbyclor$330$23,51654 claims
Boehringer IngelheimJardiance$100$19,07316 claims
AstraZenecaFarxiga$578$15,97524 claims
Kowa Pharmaceuticals America, Inc.Livalo$117$12,18419 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,533 family medicine providers in California.

Other family medicine in Los Alamitos

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →